Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor.

@article{Kaemmerer2009NeoadjuvantPR,
  title={Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor.},
  author={Daniel Kaemmerer and Vikas Prasad and Wolfgang Daffner and Dieter Hoersch and Guenter Kloeppel and Merten Hommann and Richard Paul Baum},
  journal={World journal of gastroenterology},
  year={2009},
  volume={15 46},
  pages={5867-70}
}
Pancreatic endocrine tumors are rare but are among the most common neuroendocrine neoplasms of the abdomen. At diagnosis many of them are already advanced and difficult to treat. We report on an initially inoperable malignant pancreatic endocrine tumor in a 33-year-old woman, who received neoadjuvant peptide receptor radionuclide therapy (PRRT) as first-line treatment. This resulted in a significant downstaging of the tumor and allowed its subsequent complete surgical removal. Follow-up for… CONTINUE READING
26 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

Similar Papers

Loading similar papers…